Navigation Links
Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
Date:12/19/2007

macologic therapy and simple analgesics, for example, acetaminophen. Synvisc is currently approved in Europe and Canada to treat pain due to osteoarthritis in the knee and hip, and also approved in Europe for the ankle and shoulder indications, covering the major joints.

In clinical trials, the most commonly reported adverse events were transient local pain, swelling, and/or effusion in the injected knee. In some cases, these symptoms have been extensive. Other side effects such as rash have been reported rarely. Synvisc is contraindicated in patients with known hypersensitivity to hyaluronan products or patients with infections in or around the knee. Healthcare practitioners should exercise caution when using Synvisc in patients allergic to avian proteins, feathers, or egg products; who have evidence of venous or lymphatic stasis in the leg to be treated; or who have severe inflammation in the knee joint to be treated. Patients should be advised to avoid strenuous or prolonged weight-bearing activities after treatment. Strict adherence to aseptic technique must be followed to avoid joint infection. The safety and effectiveness of Synvisc in children and in pregnant or lactating women have not been established. It is unknown whether Synvisc is excreted in human milk.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services help
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... METTLER TOLEDO’s newly improved XS balance line includes ... well as a dual range microbalance . As ... weighing pan delivers results up to twice as fast, ... design details mean users no longer need to suffer ... in front of the balance. Barbara Bienlein, medical specialist ...
(Date:10/1/2014)... Mass. , Oct. 1, 2014  Pressure BioSciences, ... leader in the development and sale of high pressure-based ... today announced it has been invited to present at ... Warsaw , Poland.  The Conference will ... 2, 2014.  Mr. Richard T. Schumacher , President ...
(Date:10/1/2014)... , Oct. 1, 2014  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, announced today ... VTech and Uniden in the U.S. District Court ... has been rescheduled for November 10, ... 2, 2014.  The Court Order setting the Markman ...
(Date:10/1/2014)... CA (PRWEB) October 01, 2014 As the ... leaves no room for doubt that this century would mark ... in the field of medicine science. The fact that the ... is not unknown to the scientific community. Almost half of ... and therefore can be prevented with medical care and intervention. ...
Breaking Biology Technology:METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 2METTLER TOLEDO’s XS Balance Line Delivers Performance and Ergonomics To Safeguard Health in the Workplace 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 2Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 4Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 2Fighting Mortality and Morbidity of Chronic Health Disorders during Open Access Week 3
... announces the introduction of web-based Spanish-language ... La., June 9 Lee Pryor, Portico,s CEO,commented, ... Spanish will,enable small and mid-size companies worldwide to ... transmitidos por la sangre, the Spanish,version of one ...
... Practices ... Costs, SAN FRANCISCO and BRUSSELS, June 7 ... Epidemiology and Prevention warned,today that recent research demonstrates ... are closely related, and that both disorders,have significant ...
... transition from imitator to innovator in health-related products, according to ... facing that country,s health biotech industry. , In ... Global Health (MRC), says South America,s largest and most populous ... a major global player. It is held back, however, ...
Cached Biology Technology:LMXonline Offers Spanish-Language Safety and Health Training Library 2IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 2IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 3IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea 4Brazil's biotech firms: From imitators to innovators in health-related products 2Brazil's biotech firms: From imitators to innovators in health-related products 3Brazil's biotech firms: From imitators to innovators in health-related products 4Brazil's biotech firms: From imitators to innovators in health-related products 5Brazil's biotech firms: From imitators to innovators in health-related products 6
(Date:9/30/2014)... report that a new class of chemical compounds ... They have also pinpointed the relevant target enzyme, ... , Researchers led by LMU,s Professor Angelika ... Universitt Mnchen have identified a class of chemicals ... fight against malignant tumors. The compound is itself ...
(Date:9/30/2014)... This news release is available in German . ... differ in their behavioural response to risky situations such ... Institute for Ornithology now found in a long-term study ... correlates with both metabolic rate and ambient temperature. High ... risk-taking behaviour, as in these scenarios birds were more ...
(Date:9/30/2014)... Ill. (September 30, 2014) People who suffer from ... do to control their asthma besides properly taking medications ... new article in the Annals of Allergy, Asthma ... College of Allergy, Asthma and Immunology (ACAAI), asthma sufferers ... their lifestyle. The woman described in the Annals article ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Risky metabolism 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... the back of a leaf and the tip is different from ... Arabidopsis plant superficially appears to be bilaterally symmetrical, or the ... fool you; there is an underlying asymmetry between the left and ... to discover it. The story begins with the mechanism by which ...
... an enzyme that is involved in a modification pathway ... no similarity to other known proteins, it may be ... Studies on a number of pathogenic bacteria ... an enzyme called elongation factor P (EF-P) is chemically ...
... multidisciplinary team of researchers at MIT and in Spain ... electronic behavior of noncrystalline materials, which may eventually play ... organic LED lights and printable, flexible electronic circuits. ... not previously been applied in physics or chemistry. Even ...
Cached Biology News:Is your leaf left-handed? 2Is your leaf left-handed? 3New technique allows simulation of noncrystalline materials 2New technique allows simulation of noncrystalline materials 3
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
In plasmid or lambda vector. Please inquire for more details!...
ANTI-RAT ADHESION MARKERS, CDs, CYTOKINES, ETC Rat ICAM PE - Mouse IgG1...
Biology Products: